Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells

被引:234
作者
Okamoto, T
Aoyama, T
Nakayama, T
Nakamata, T
Hosaka, T
Nishijo, K
Nakamura, T
Kiyono, T
Toguchida, J
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Sakyo Ku, Kyoto 6068057, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068057, Japan
[3] Aichi Canc Ctr, Res Inst, Div Virol, Chigusa Ku, Nagoya, Aichi 4648681, Japan
关键词
mesenchymal stem cell; telomerase; immortalization; HPV16E6; HPV16E7; Rb; p16; differentiation;
D O I
10.1016/S0006-291X(02)00661-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesenchymal stem cells (MSCs) are bone marrow stroma-derived cells, which can differentiate into several types of mesenchymal tissues. Although regarded as tissue-specific stem cells, human MSCs (hMSCs) have a low proliferative ability with a finite life span, which is a hurdle to further analysis of their biology. Here we attempted to establish immortalized hMSCs by retrovirus-mediated gene transfer. The gain in telomerase activity obtained on expression of human telomerase reverse transcriptase (hTERT) was found not to be enough to make the cell line immortal. A combination of hTERT with human papillomavirus E6 and E7 successfully immortalized hMSCs without affecting the potential for adipogenic, osteogenic, and chondrogenic differentiation. From the parental immortalized hMSC, 100 single-cell derived clones were established, of which the differentiation properties varied considerably, including tri-, bi-, and uni-directional clones, suggesting that hMSCs are constituted by a group of cells with different differentiation potential. These cell lines, being the first established immortalized clonal cell lines of hMSCs, could provide insights into the mechanisms regulating the early steps of differentiation from undifferentiated MSCs into a specific lineage. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:354 / 361
页数:8
相关论文
共 40 条
  • [31] Differentiation of immortal cells inhibits telomerase activity
    Sharma, HW
    Sokoloski, JA
    Perez, JR
    Maltese, JY
    Sartorelli, AC
    Stein, CA
    Nichols, G
    Khaled, Z
    Telang, NT
    Narayanan, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) : 12343 - 12346
  • [32] Tatematsu K, 1996, ONCOGENE, V13, P2265
  • [33] Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase
    Thomas, M
    Yang, LQ
    Hornsby, PJ
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (01) : 39 - 42
  • [34] EVIDENCE FOR A MITOTIC CLOCK IN HUMAN HEMATOPOIETIC STEM-CELLS - LOSS OF TELOMERIC DNA WITH AGE
    VAZIRI, H
    DRAGOWSKA, W
    ALLSOPP, RC
    THOMAS, TE
    HARLEY, CB
    LANSDORP, PM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) : 9857 - 9860
  • [35] MYOGENIC CELLS DERIVED FROM RAT BONE-MARROW MESENCHYMAL STEM-CELLS EXPOSED TO 5-AZACYTIDINE
    WAKITANI, S
    SAITO, T
    CAPLAN, AI
    [J]. MUSCLE & NERVE, 1995, 18 (12) : 1417 - 1426
  • [36] WATT FM, 2001, CURR OPIN GENE DEV, V21, P367
  • [37] Stem cells: Units of development, units of regeneration, and units in evolution
    Weissman, IL
    [J]. CELL, 2000, 100 (01) : 157 - 168
  • [38] THE 2-STAGE MECHANISM CONTROLLING CELLULAR SENESCENCE AND IMMORTALIZATION
    WRIGHT, WE
    SHAY, JW
    [J]. EXPERIMENTAL GERONTOLOGY, 1992, 27 (04) : 383 - 389
  • [39] Telomerized human microvasculature is functional in vivo
    Yang, JW
    Nagavarapu, U
    Relloma, K
    Sjaastad, MD
    Moss, WC
    Passaniti, A
    Herron, GS
    [J]. NATURE BIOTECHNOLOGY, 2001, 19 (03) : 219 - 224
  • [40] Constructing immortalized human cell lines
    Yeager, TR
    Reddel, RR
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (05) : 465 - 469